Summary Mistral AI, in partnership with consulting firm Carbone 4 and France’s ecological transition agency (ADEME), has released a report that evaluates the environmental impact of its Mistral Large 2…
Summary The FDA has introduced an AI tool named Elsa, designed to streamline drug approvals. Surprisingly, it has been reported that Elsa is generating fictitious studies, raising concerns about its…
Summary Mistral AI has released an extensive report detailing the environmental impact of its AI models, revealing the staggering amounts of water and power used during the training of its…
Summary The FDA’s new AI tool named Elsa has started generating false studies as part of its drug approval process. While it was intended to increase efficiency, reports suggest that…
Summary The FDA’s new AI tool, Elsa, has come under fire for generating fictitious studies, raising significant concerns about its reliability. Initially intended to streamline the drug approval process, Elsa…
FDA’s New Drug Approval AI Is Generating Fake Studies The FDA’s AI tool, Elsa, designed to assist in drug approvals, is reportedly generating fake studies. Despite the push from Robert…
Summary FDA’s new AI tool, Elsa, is reportedly producing inaccurate and fabricated studies in the drug approval process. While some employees find Elsa useful for administrative tasks, others raised concerns…
FDA’s New Drug Approval AI Is Generating Fake Studies An alarming report has surfaced regarding the FDA’s new AI tool, Elsa, which is purportedly generating fake studies. While some employees…
Summary Reports indicate that the FDA’s AI tool, Elsa, designed to assist in drug approval processes, is generating fictitious studies and misrepresenting existing research. This has raised significant concerns among…
Summary The FDA’s new AI tool, Elsa, aimed at expediting drug approvals, is reportedly generating fake studies. While some employees found Elsa useful for tasks like summarising meetings, others highlighted…
